OFM

Omega Fund Management Portfolio holdings

AUM $154M
This Quarter Return
+30.15%
1 Year Return
-32.78%
3 Year Return
+82.35%
5 Year Return
+29.08%
10 Year Return
+90.46%
AUM
$667M
AUM Growth
+$667M
Cap. Flow
+$202M
Cap. Flow %
30.22%
Top 10 Hldgs %
91.1%
Holding
20
New
4
Increased
–
Reduced
5
Closed
1

Top Buys

1
KRON
Kronos Bio
KRON
$114M
2
SPRB
Spruce Biosciences, Inc. Common Stock
SPRB
$52.5M
3
AVIR icon
Atea Pharmaceuticals
AVIR
$35.4M
4
SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$17M

Top Sells

1
REPL icon
Replimune Group
REPL
$10.3M
2
EPIX icon
ESSA Pharma
EPIX
$2.47M
3
PRVL
Prevail Therapeutics Inc. Common Stock
PRVL
$1.91M
4
MORF
Morphic Holding, Inc. Common Stock
MORF
$1.88M
5
ARQT icon
Arcutis Biotherapeutics
ARQT
$526K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
REPL icon
1
Replimune Group
REPL
$422M
$194M 29.03% 5,074,783 -270,188 -5% -$10.3M
KRON
2
DELISTED
Kronos Bio
KRON
$114M 17.1% +3,818,283 New +$114M
MORF
3
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$98M 14.7% 2,921,771 -56,061 -2% -$1.88M
SPRB
4
DELISTED
Spruce Biosciences, Inc. Common Stock
SPRB
$52.5M 7.88% +2,161,022 New +$52.5M
AVIR icon
5
Atea Pharmaceuticals
AVIR
$267M
$35.4M 5.31% +847,208 New +$35.4M
GOSS icon
6
Gossamer Bio
GOSS
$562M
$32.1M 4.82% 3,320,608 – –
IMUX icon
7
Immunic
IMUX
$80.9M
$27.3M 4.1% 1,788,160 – –
CMPI
8
DELISTED
Checkmate Pharmaceuticals, Inc. Common Stock
CMPI
$19.5M 2.92% 1,335,050 – –
ARQT icon
9
Arcutis Biotherapeutics
ARQT
$1.86B
$18M 2.7% 640,199 -18,709 -3% -$526K
SYRS
10
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$17M 2.54% +1,562,500 New +$17M
PRTK
11
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$16.3M 2.44% 2,600,410 – –
ALPN
12
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
$16.2M 2.43% 1,284,900 – –
EPIX icon
13
ESSA Pharma
EPIX
$11.4M
$8.42M 1.26% 705,693 -207,000 -23% -$2.47M
FGEN icon
14
FibroGen
FGEN
$47.8M
$4.85M 0.73% 130,646 – –
CDTX icon
15
Cidara Therapeutics
CDTX
$1.66B
$4.01M 0.6% 2,005,249 – –
TRVI icon
16
Trevi Therapeutics
TRVI
$883M
$3.33M 0.5% 1,263,408 -112,499 -8% -$297K
JNCE
17
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$2.35M 0.35% 334,965 – –
OBSV
18
DELISTED
ObsEva SA Ordinary Shares
OBSV
$2.08M 0.31% 999,364 – –
PVLA
19
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
$1.88M 0.28% 750,741 – –
PRVL
20
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
– – -187,538 Closed -$1.91M